Major Tobacco Manufacturer Selects ArisGlobal's LifeSphere(R) MultiVigilance to Automate All Global Internal Adverse Event Management Processes

PR82785

MIAMI, Feb. 11, 2020 /PRNewswire=KYODO JBN/--

- A multinational tobacco products manufacturing company recently selected

ArisGlobal's LifeSphere(R) MultiVigilance 10 for their global safety vigilance

needs

ArisGlobal, the leading provider of life sciences software that automates core

drug development functions for over 250 life sciences companies, today

announced one of the world's largest tobacco manufacturing companies has

selected LifeSphere(R) MultiVigilance 10

[https://www.arisglobal.com/products/lifesphere-multivigilance/] (LSMV10) as

its global safety vigilance system. The company's main objective is to

internalize safety vigilance, which was previously managed by a third party

CRO, to achieve maximum cost-effectiveness through end-to-end automation.

LifeSphere(R) MultiVigilance 10 is the industry's first and only adverse event

platform to seamlessly integrate product quality complaint and medical

information systems into a single, integrated platform, thus enabling the

exchange of safety cases between these critical functions.

"We are very pleased to have this global organization adopt ArisGlobal's

multi-tenant LifeSphere(R) MultiVigilance 10," said Sankesh Abbhi

[https://www.linkedin.com/in/sankesh-abbhi-502397b/], ArisGlobal's President

and CEO. "We offer the world's largest and most innovative multi-tenant safety

cloud. This tobacco company is an example of how customers can manage adverse

events on an end-to-end basis by leveraging our leading technology. LSMV10 is

production-ready, has been extensively tested, and is currently being used by a

major regulatory agency in the United States. It is also being utilized by

several leading pharma companies who worked with us to identify

business-critical problems within case processing and then assisted us in

finding innovative ways to solve them."

Learn more: For more on LifeSphere(R) Multivigilance 10, visit:

https://www.arisglobal.com/products/LSMV10/.

About ArisGlobal

ArisGlobal is transforming the way today's most successful Life Sciences

companies develop breakthroughs and bring new products to market. Our

end-to-end drug development technology platform, LifeSphere(R), integrates our

proprietary Nava(R) cognitive computing engine to automate all core functions

of the drug development lifecycle. Designed with deep expertise and a long-term

perspective that spans more than 30 years, LifeSphere(R) is a unified platform

that boosts efficiency, ensures compliance, delivers actionable insights, and

lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe,

India, Japan and China. For more updates, follow ArisGlobal on LinkedIn

[https://www.linkedin.com/company/aris-global/] and Twitter

[https://twitter.com/Aris_Global].

Logo - https://mma.prnewswire.com/media/523994/ArisGlobal_Logo.jpg

Contact:

Alberto Cantor

Senior Manager, Corporate Marketing

+1-609-360-4042

Source: ArisGlobal